Location: Boston, MA
CIK: 0001732811 · Show all filings
Period: Q2 2019 (← Previous) (Next →)
Filing Date: Aug 14, 2019
Total Value: $630M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ALLERGAN PLC | 900,101 | $151M | 23.9% | $143.04 | — | SHS | G0177J108 |
| FOXA | FOX CORP | 2,369,331 | $86.81M | 13.8% | $35.41 | -5.2% | CL A COM | 35137L105 |
| PCG | PG&E CORP | 2,800,000 | $64.18M | 10.2% | $21.11 | -5.9% | COM | 69331C108 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 4,939,541 | $54.04M | 8.6% | $11.48 | -2.4% | COM CL A | 46333X108 |
| XPO | XPO LOGISTICS INC | 913,935 | $52.84M | 8.4% | $27.03 | -24.6% | COM | 983793100 |
| LNG | CHENIERE ENERGY INC | 750,000 | $51.34M | 8.1% | $61.54 | +7.6% | COM NEW | 16411R208 |
| GS | GOLDMAN SACHS GROUP INC | 173,811 | $35.56M | 5.6% | $170.89 | -1.0% | COM | 38141G104 |
| — | PIONEER NAT RES CO | 200,000 | $30.77M | 4.9% | $131.52 | — | COM | 723787107 |
| — | FGL HLDGS | 3,000,000 | $25.2M | 4.0% | $7.72 | — | ORD SHS | G3402M102 |
| — | GTT COMMUNICATIONS INC | 1,250,000 | $22M | 3.5% | $22.45 | — | COM | 362393100 |
| — | CYCLERION THERAPEUTICS INC | 1,487,874 | $17.04M | 2.7% | $11.45 | — | COM | 23255M105 |
| — | LIBERTY GLOBAL PLC | 625,558 | $16.6M | 2.6% | $26.53 | — | SHS CL C | G5480U120 |
| TAK | TAKEDA PHARMACEUTICAL CO LTD | 785,000 | $13.89M | 2.2% | $20.37 | — | SPONSORED ADS | 874060205 |
| NAVI | NAVIENT CORPORATION | 244,300 | $3.335M | 0.5% | $11.45 | +13.9% | COM | 63938C108 |
| ACRS | ACLARIS THERAPEUTICS INC | 1,500,000 | $3.285M | 0.5% | $10.31 | -47.1% | COM | 00461U105 |
| EOLS | EVOLUS INC | 120,000 | $1.754M | 0.3% | $19.82 | 0.0% | COM | 30052C107 |
| — | REVANCE THERAPEUTICS INC | 46,000 | $597K | 0.1% | $20.13 | — | COM | 761330109 |